Journal
FUTURE CARDIOLOGY
Volume 3, Issue 4, Pages 413-423Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/14796678.3.4.413
Keywords
-
Categories
Funding
- National Institutes of Health [R01 HL078691, HL057263, HL071763, HL080498, HL083156]
- Leducq Foundation Transatlantic Network
Ask authors/readers for more resources
Heart failure is a major cause of morbidity and mortality in Western countries. While progress in conventional treatment modalities is making steady and incremental gains to reduce this disease burden, there remains a need to explore new and potentially therapeutic approaches. Gene therapy, for example, was initially envisioned as a treatment strategy for inherited monogenic disorders. It is now apparent that gene therapy has broader potential, which also includes acquired polygenic diseases such as heart failure. Advances in the understanding of the molecular basis of conditions such as these, together with the evolution of increasingly efficient gene transfer technology, has placed congestive heart failure within the reach of gene-based therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available